Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit
Silexion Therapeutics Corp. (NASDAQ: SLXN) to participate in 2024 Maxim Healthcare Virtual Summit, presenting innovative RNAi therapies for difficult-to-treat cancers.
This news matters as it highlights Silexion Therapeutics' participation in a significant healthcare summit, showcasing their innovative RNAi therapies for difficult-to-treat cancers, which could potentially improve outcomes for patients.